...
首页> 外文期刊>Chinese Journal of Integrated Traditional and Western Medicine >Clinical Study on Early Post-operational Intraperitoneal Chemotherapy and Salviae in Treating Patients of Gastric Cancer
【24h】

Clinical Study on Early Post-operational Intraperitoneal Chemotherapy and Salviae in Treating Patients of Gastric Cancer

机译:术后早期腹腔化疗和丹参治疗胃癌的临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

Conclusions: Combined therapy of SM and 5-FU in treating patients with gastric cancer by intraper- itoneal infusion is not only safe and feasible with mild toxic and side effect, but also produces a more bene- ficial effects, including less intra-abdominal recurrence and satisfactory short-term survival rate . Objective: To evaluate the safety, feasibility and short-term efficacy of early post-opera- tional intraperitoneal chemotherapy (EPIC) combined with Salviae miltiorrhizae (SM) in treating patients with gastric cancer. Methods: The 136 patients enrolled were divided into 3 groups: the EPIC group, the EPVC group and the control group.
机译:结论:SM和5-FU联合腹膜内输注治疗胃癌不仅安全,可行,而且有轻度的毒副作用,而且产生的益处更大,包括腹腔内复发少和令人满意的短期生存率。目的:评价早期手术后腹膜内化疗(EPIC)联合丹参(SM)联合治疗胃癌的安全性,可行性和近期疗效。方法:将136例患者分为3组:EPIC组,EPVC组和对照组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号